missing translation for 'onlineSavingsMsg'
Learn More
Learn More
R&D Systems™ Recombinant Human FGF basic/FGF2/bFGF (157 aa) Protein
Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity
Brand: R&D Systems™ 234-FSE-025/CF
This item is not returnable.
View return policy
Description
The Recombinant Human FGF basic/FGF2 (157 aa) Protein is derived from E. coli. The Recombinant Human FGF basic/FGF2 (157 aa) Protein has been validated for the following applications: Bioactivity.Specifications
| Supplied as a 0.2μm filtered solution in Tris-HCl and NaCl. | |
| 17.4 kDa | |
| 25 μg | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution. | |
| Basic fibroblast growth factor, basic fibroblast growth factor bFGF, bFGF, FGF2, FGF-2, FGFBprostatropin, fibroblast growth factor 2 (basic), HBGF-2, heparin-binding growth factor 2, Prostatropin | |
| Recombinant |
| 2247 | |
| FGF basic 157 aa | |
| E. coli-derived human FGF basic/FGF2/bFGF protein Gly132-Ser288 | |
| <0.1 EU per 1μg of the protein by the LAL method. | |
| Unconjugated | |
| 97%, by SDS-PAGE under reducing conditions and visualized by silver stain. |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction